Split Creek Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Split Creek Capital's GILD Position: Q3 2026 in Review
Split Creek Capital sold out of Gilead Sciences (GILD) in Q3 2026, closing a stake of 2,225 shares — an estimated $281K sold.
Split Creek Capital first reported a position in GILD in Q2 2026 and held it in 1 quarter. The position peaked at $281K in Q2 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Split Creek Capital reported no remaining Gilead Sciences position as of Q3 2026 after selling out during the quarter.
- Split Creek Capital sold 2,225 Gilead Sciences shares in Q3 2026, an estimated $281K.
- Split Creek Capital first reported a position in Gilead Sciences in Q2 2026 and held it in 1 quarter.
- Split Creek Capital's Gilead Sciences position peaked at $281K in Q2 2026.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.